Sa1755 EFFECTIVENESS AND SAFETY OF ABP501, AN ADALIMUMAB BIOSIMILAR, IN NAÏVE PATIENTS WITH IBD AND IN THOSE UNDERGOING SWITCHING FROM ADALIMUMAB ORIGINATOR: A MULTICENTRIC NORTH ITALIAN STUDY.